AIDS InfoNet Logo
This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

The Henry J. Kaiser Family Foundation
Site of the Week
November 2003

The Health Leader Award 2006
The Health Leader Award 2006

The HOPE Reward

Med411.com Medical Award

HealthAtoZ.com Featured Site Award

BuscaSalud.com

IBS Tales Hope Award

HealingWell.com Editor's Choice Award

Listed in Listed in Treasures of the Internet


AIDS InfoNet Logo.  The AIDS InfoNet - Reliable, Up-to-Date AIDS Treatment Information
International Association of Providers of AIDS Care
Reviewed April 16, 2014

Fact Sheet 515

Pneumocystis Pneumonia (PCP)


 WHAT IS PCP?
HOW IS PCP TREATED?
CAN PCP BE PREVENTED?
WHICH DRUG IS BEST?
THE BOTTOM LINE
 


WHAT IS PCP?

Pneumocystis pneumonia (PCP or pneumocystis) is the most common opportunistic infection in people with HIV. Without treatment, over 85% of people with HIV would eventually develop PCP. It has been the major killer of people with HIV. Although PCP is now almost entirely preventable and treatable, it still causes death in about 10% of cases.

Currently, with strong antiretroviral therapy (ART, see fact sheet 403) available, PCP rates have dropped dramatically. Unfortunately, PCP is still common in people who are infected with HIV for a long time before getting treatment. In fact, 30% to 40% of people with HIV develop PCP if they wait to get treatment until their CD4 cell counts are around 50. The best way to reduce cases of PCP is testing for HIV to identify cases sooner.

PCP is caused by a fungus. It used to be called pneumocystis carinii, but scientists now call it pneumocystis jiroveci. A healthy immune system can control the fungus. However, PCP causes illness in children and in adults with a weakened immune system.

Pneumocystis almost always affects the lungs, causing a form of pneumonia. People with CD4 cell counts (see Fact Sheet 124) under 200 have the highest risk of developing PCP. People with counts under 300 who have already had another opportunistic infection are also at risk. Most people who get PCP become much weaker, lose a lot of weight, and are likely to get PCP again.

The first signs of PCP are difficulty breathing, fever, and a dry cough. Anyone with these symptoms should see a health care provider immediately. However, everyone with CD4 counts below 300 should discuss PCP prevention with their health care provider, before they experience any symptoms.

 


HOW IS PCP TREATED?

For many years, antibiotics were used to prevent PCP in cancer patients with weakened immune systems. In 1985 a study showed that these drugs would also prevent PCP in people with AIDS.

The drugs used to treat PCP include TMP/SMX, dapsone, pentamidine, and atovaquone.

TMP/SMX (Bactrim or Septra, see Fact Sheet 535) is the most effective anti-PCP drug. It’s a combination of two antibiotics: trimethoprim (TMP) and sulfamethoxazole (SMX).
Dapsone (see Fact Sheet 533) is similar to TMP/SMX. Dapsone seems to be almost as effective as TMP/SMX against PCP.
Pentamidine (NebuPent, Pentam, Pentacarinat) (see Fact Sheet 537) is a drug that is usually inhaled in an aerosol form to prevent PCP. Pentamidine is also used intravenously (IV) to treat active PCP.
Atovaquone (Mepron) (see Fact Sheet 538) is a drug used in people with mild or moderate cases of PCP who cannot take TMP/SMX or pentamidine.

Based on a small study, if standard therapy doesn’t work, patients might be able to use Neutrexin (trimetrexate) combined with Leucovorin (folinic acid.)

 


CAN PCP BE PREVENTED?

The best way to prevent PCP is to use strong ART. People who have less than 200 CD4 cells can prevent PCP by taking the same medications used for PCP treatment.

Another way to reduce the risk of PCP is not to smoke, or to stop smoking. HIV-positive smokers develop PCP two to three times faster than HIV-positive people who do not smoke. One study found that ex-smokers who stopped for at least a year developed PCP no quicker than non-smokers.

Combination ART can make your CD4 cell count go up. If it goes over 200 and stays there for 3 months, it may be safe to stop taking PCP medications. However, because PCP medications are inexpensive and have mild side effects, some researchers think they should be continued until your CD4 cell count reaches 300. Be sure to talk with your health care provider before you stop taking any of your prescribed medications.

 


WHICH DRUG IS BEST?

Bactrim or Septra (TMP/SMX) is the most effective drug against PCP. It is also inexpensive, costing only about $10 per month. It is taken in pill form, not more than one pill daily. Cutting back from one pill a day to three pills a week reduces the allergy problems of Bactrim and Septra, and seems to work just as well.

However, the “SMX” part is a sulfa drug and almost half of the people who take it have an allergic reaction. This usually is a skin rash, sometimes a fever. Allergic reactions can be overcome using a desensitization procedure. Patients start with a very small amount of the drug and take increasing amounts until they can tolerate the full dose.

Dapsone causes fewer allergic reactions than TMP/SMX. It is also fairly inexpensive - about $30 per month. It also is taken as a pill and, like Bactrim or Septra, not more than one pill daily.

Pentamidine involves a monthly visit to a clinic with a nebulizer, the machine that produces a very fine mist of the drug. The mist is inhaled directly into the lungs. The procedure takes about 30 to 45 minutes. You pay for the drug plus the clinic costs, between $120 and $250 per month. Patients using aerosol pentamidine get PCP more often than people taking the antibiotic pills.

 


THE BOTTOM LINE

PCP is now almost totally treatable and preventable. However, it is still common in people who do not know they are infected with HIV. Strong antiretroviral drugs (ARVs) can keep the CD4 cell count from dropping. If your CD4 cell count is below 300, talk to your health care provider about taking drugs to prevent PCP. Everyone whose CD4 cell count is below 200 should be taking anti-PCP medication.

 


 


Back to Fact Sheet Categories



New Mexico AIDS Education and Training Center The University of New Mexico Health Sciences Center International Association of Providers of AIDS Care

 

The AIDS InfoNet is a project of the New Mexico AIDS Education and Training Center at the University of New Mexico Health Sciences Center,
and the International Association of Providers of AIDS Care.
webmaster@aidsinfonet.org

 

United States National Library of Medicine

Partially funded by the National Library of Medicine



Search Our Site
Newest Fact Sheets
Print This Fact Sheet
You can print this fact sheet on a single page in Microsoft Word (.doc) format or Adobe Acrobat (.pdf) format. Click on the links below to open the document in your browser and then print it.
 Adobe Acrobat PDF
 Microsoft Word

You can print directly from your browser using the link below. The printout will probably go onto a second page.
 Print Version (Web)

Monthly E-mail Updates

The InfoNet updates its Fact Sheets frequently. A listing of each month's changes is posted to several e-mail lists.

If you would like to receive this monthly update by personal e-mail, please click on the SUBMIT button.

SUBMIT